B. Riley Has Bullish Outlook for CRBP FY2025 Earnings
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Stock analysts at B. Riley increased their FY2025 earnings per share estimates for Corbus Pharmaceuticals in a research note issued to investors on Thursday, March 13th. B. Riley analyst K. Patel now expects that the biopharmaceutical company will post earnings per share of ($3.70) for the […]
